Stephen Pyke, chief clinical data and digital officer, Parexel discusses:
- A broad overview of the use of artificial intelligence in clinical development and how regulatory bodies are viewing it
- How AI can be used in clinical trials to streamline operational processes
- The importance of collaboration and data sharing in advancing the use of technology, and more
- The importance of considering the experience of patients when integrating artificial intelligence as well as some of the benefits they will see from it
- Human oversight when using artificial intelligence to aid in decision making
Gadi Saarony, CEO of Advarra examines:
- The current state of diversity in clinical research
- The need for industry to take more action in making trials more diverse
- What regulatory bodies need to do to increase awareness
- How researchers can best reach diverse populations
Marie Teil, Global Head of UCB’s Women of Childbearing Age Program, discusses:
- Specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials
- UCB's Women of Childbearing Age Program and it’s most successful strategies
- The role of technology in addressing the data gap in women's health research
Micah Lieberman, Executive Director, Conferences (CHI) & Co-Founder, VP, Community and Business Development (ClinEco) shares:
- The origin story of ClinEco
- Why he felt the clinical trials industry needed a more centralized ecosystem
- The SCOPE Europe conference and more!
Flo Mowlem, VP of Science at ObvioHealth:
- Highlights her career path and experience with eCOA
- Discusses what is currently happening in the digital clinical trials space
- & How to manage the unique challenges they bring including device accessibility and remote patient monitoring